Beatriz Wills (@beatrizwills) 's Twitter Profile
Beatriz Wills

@beatrizwills

Hematologist/ Oncologist.Interested in CAR-T, co-host @tumortalks , global oncology.@MSKCancerCenter, @JohnsHopkinsHospital,@FSFB

ID: 1283568846880858116

calendar_today16-07-2020 01:07:27

62 Tweet

265 Takipçi

512 Takip Edilen

Stephen V Liu, MD (@stephenvliu) 's Twitter Profile Photo

Lifileucel, autologous tumor infiltrating lymphocyte (TIL) cell therapy) in NSCLC post-IO Cancer Discovery. 36d from collection to TIL infusion. RR 21.4% (6/28), including 1 ongoing at 26+ months. Expected Flu/Cy & TIL toxicity but 2 deaths from adverse events. aacrjournals.org/cancerdiscover…

Raul Cordoba, MD, PhD #WCLLD24 (@drraulcordoba) 's Twitter Profile Photo

Excelente presentación de Miguel Canales (Clínica Universidad de Navarra) sobre el tratamiento de Linfoma Difuso de Células Grandes #LDCBG en el evento #BloodInnovationForum2024 de Roche México 🇲🇽 en Monterrey, Nuevo León #lymsm #HematologíaEnEspañol @sehh_es AMEH A.C.

Excelente presentación de <a href="/DrMCanales/">Miguel Canales</a> (<a href="/ClinicaNavarra/">Clínica Universidad de Navarra</a>) sobre el tratamiento de Linfoma Difuso de Células Grandes #LDCBG en el evento #BloodInnovationForum2024 de <a href="/Roche/">Roche</a> México 🇲🇽 en Monterrey, Nuevo León #lymsm #HematologíaEnEspañol <a href="/sehh_es/">@sehh_es</a> <a href="/ContactoAmeh/">AMEH A.C.</a>
ASH (@ash_hematology) 's Twitter Profile Photo

Calling all fellows & early-to mid-career #hematology faculty working in Latin American countries! Apply for the ASH Clinical Research Training Institute in Lain America! CRTI-LA includes didactic sessions, breakout groups & mentoring opportunities. Apply: ow.ly/gXvt50SuKO8

Calling all fellows &amp; early-to mid-career #hematology faculty working in Latin American countries! Apply for the ASH Clinical Research Training Institute in Lain America! CRTI-LA includes didactic sessions, breakout groups &amp; mentoring opportunities. Apply: ow.ly/gXvt50SuKO8
Marcel van den Brink (@drmvandenbrink) 's Twitter Profile Photo

FDA Approves CAR T Cell Treatment for Resistant Mantle Cell Lymphoma | Memorial Sloan Kettering Cancer Center mskcc.org/news/fda-appro…

Klebanoff_Lab (@klebanofflab) 's Twitter Profile Photo

🙌🧬It’s official: the first TCR gene therapy for the treatment of cancer received U.S. FDA approval this evening. A milestone event for the oncology community and the 2nd cell therapy approved for solid cancers! Adaptimmune #Tcellpower adaptimmune.com/investors-and-…

LABMT (@labmt2) 's Twitter Profile Photo

Are you interested in developing an academic #CART clinical trial in your institution? Join our CARLA consortium and collaborate with colleages in Latin America working hard to implement these therapies in our region! Link: forms.gle/yWoHxUueypJFE3…

Are you interested in developing an academic #CART clinical trial in your institution?

Join our CARLA consortium and collaborate with colleages in Latin America working hard to implement these therapies in our region! 

Link: forms.gle/yWoHxUueypJFE3…
Lymphoma Hub (@lymphomahub) 's Twitter Profile Photo

CONGRESS | #SOHO2024 Gilles Salles Memorial Sloan Kettering Cancer Center discusses how to sequence therapies in R/R DLBCL, with the aim to optimize the chance of cure; concluding with a look to the future landscape and the possibility of achieving a cure amongst a substantial fraction of patients.

CONGRESS | #SOHO2024
<a href="/gilles_salles/">Gilles Salles</a> <a href="/MSKCancerCenter/">Memorial Sloan Kettering Cancer Center</a> discusses how to sequence therapies in R/R DLBCL, with the aim to optimize the chance of cure; concluding with a look to the future landscape and the possibility of achieving a cure amongst a substantial fraction of patients.